Assessment of efficacy of a bivalent BTV-2 and BTV-4 inactivated vaccine by vaccination and challenge in cattle

Veterinary Microbiology

Volumn 133, Issue 1-2, 2009, Pages 1-8

  Savini, G ^a   Hamers, C ^b   Conte, A ^a   Migliaccio, P ^a   Bonfini, B ^a   Teodori, L ^a   Di Ventura, M ^a   Hudelet, P ^b   Schumacher, C ^b   Caporale, V ^a  

^a ISTITUTO ZOOPROFILATTICO SPERIMENTALE DELL ABRUZZO E DEL MOLISE G CAPORALE   (Italy)

^b BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

Bluetongue virus serotype 2; Bluetongue virus serotype 4; Cattle; Inactivated vaccine

Indexed keywords

BLUETONGUE VIRUS 2 INACTIVATED VACCINE; BLUETONGUE VIRUS 4 INACTIVATED VACCINE; INACTIVATED VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; BLUETONGUE ORBIVIRUS; CATTLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; NONHUMAN; SEROLOGY; SEROTYPE; VACCINATION; VIREMIA; VIRUS ISOLATION; VIRUS NEUTRALIZATION; VIRUS STRAIN;

ANIMALS; ANTIBODIES, VIRAL; BLUETONGUE; BLUETONGUE VIRUS; CATTLE; CATTLE DISEASES; INJECTIONS, SUBCUTANEOUS; RANDOM ALLOCATION; SEROTYPING; TIME FACTORS; VACCINES, INACTIVATED; VIRAL LOAD; VIRAL VACCINES; VIREMIA;

ANIMALIA; BLUETONGUE VIRUS; BLUETONGUE VIRUS 2; BOS;

EID: 55549131493     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetmic.2008.05.032     Document Type: Article

References (41)

1. Boone J.D., Balasuriya U.B., Karaca K., Audonnet J.C., Yao J., He L., Nordgren R., Monaco F., Savini G., Gardner I.A., and MacLachlan N.J. Recombinant canarypox virus vaccine co-expressing genes encoding the VP2 and VP5 outer capsid proteins of bluetongue virus induces high level protection in sheep. Vaccine 25 (2007) 672-678
2. Calistri P., Giovannini A., Conte A., Nannini D., Santucci U., Patta C., Rolesu S., and Caporale V. Bluetongue in Italy: Part I. Vet. Ital. 40 (2004) 243-251
3. Dungu B., Gerdes T., and Smit T. The use of vaccination in the control of bluetongue in southern Africa. Vet. Ital. 40 (2004) 616-622
4. Ferrari G., De Liberato C., Scavia G., Loenzetti R., Zini M., Farina M., et al. Active circulation of bluetongue vaccine virus serotype-2 among unvaccinated cattle in central Italy. Prev. Vet. Med. 68 (2005) 103-113
5. Flanagan M., and Johnson S.J. The effects of vaccination of Merino ewes with an attenuated Australian bluetongue virus serotype 23 at different stages of gestation. Aust. Vet. J. 72 (1996) 455-457
6. Gibbs E.P., and Greiner E.C. The epidemiology of bluetongue. Comp. Immunol., Microb. Infect. Dis. 17 (1994) 197-206
7. Huismans H., and Erasmus B.J. Identification of the serotype specific and group specific antigens of bluetongue virus. Onderstepoort J. Vet. Res. 48 (1981) 51-58
8. Jeggo, M., Wright, P., Anderson, J., Eaton, B., Afshar, A., Pearson, J., Kirkland, P., Ozawa, Y., 1992. Review of the IAEA meeting in Vienna on standardization of the competitive ELISA test and reagents for the diagnosis of bluetongue. In Bluetongue, African horse sickness and related orbiviruses in: T.E. Walton and B.I. Osburn, (Eds.), Proc. Second International Symposium, Paris, 17-21 June 1991. CRC Press, Boca Raton, 547-569.
9. Katz J.B., Gustafson G.A., Alstad A.D., Adler K.A., and Moser K.M. Colorimetric diagnosis of prolonged bluetongue viremia in sheep, using an enzyme-linked oligonucleotide sorbent assay of amplified viral nucleic acids. Am. J. Vet. Res. 54 (1993) 2021-2026
10. Lelli R., Portanti O., Langella V., Luciani M., Di Emidio B., and Conte A. Produzione di un kit ELISA competitiva per la diagnosi sierologica della Bluetongue. Vet. Ital. 47 (2003) 5-13
11. Lobato Z.I., Coupar B.E., Gray C.P., Lunt R., and Andrew M.E. Antibody responses and protective immunity to recombinant vaccinia expressed-expressed bluetongue virus antigens. Vet. Immunol. Immunopathol. 59 (1997) 293-309
12. MacLachlan N.J., Osburn B.I., Stott J.L., and Ghalib H.W. Orbivirus infection of the bovine fetus. Prog. Clin. Biol. Res. 178 (1985) 79-84
13. Mellor P.S., and Wittmann E.J. Bluetongue virus in the Mediterranean Basin 1998-2001. Vet. J. 164 (2002) 20-37
14. Monaco F., Cammà C., Serini S., and Savini G. Differentiation between field and vaccine strain of bluetongue virus serotype 16. Vet. Microbiol. 116 (2006) 45-52
15. Murray P.K., and Eaton B.T. Vaccine for bluetongue. Aust. Vet. J. 73 (1996) 207-210
16. Office International Des Epizooties (OIE), Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, OIE Standards Commission (Eds.), 5th Edition, 2004.
17. OIE. World Organisation for Animal Health, 2006a. Bluetongue in The Netherlands. Disease Information, 24 August, 19, 612-613.
18. OIE. World Organisation for Animal Health, 2006b. Bluetongue in Belgium. Disease Information, 24 August, 19, 616-617.
19. OIE. World Organisation for Animal Health, 2006c. Bluetongue in Germany. Disease Information, 24 August, 19, 618.
20. OIE. World Organisation for Animal Health, 2006d. Bluetongue in France. Disease Information, 31 August, 19, 636-637.
21. OIE. World Organisation for Animal Health, 2006e. Bluetongue in Bulgaria. Disease Information, 19 October, 19, 736.
22. OIE. World Organisation for Animal Health, 2006f. Bluetongue in Italy. Disease Information, 9 November, 19, 775-776.
23. OIE. World Organisation for Animal Health, 2006g. Bluetongue in Israel. Disease Information, 30 November, 19, 842.
24. OIE. World Organisation for Animal Health, 2006h. Bluetongue in Luxembourg. Disease Information, 7 December, 19, 852.
25. Patta C., Giovannini A., Rolesu S., Nannini D., Savini G., Calistri P., et al. Bluetongue vaccination in Europe: the Italian experience. Vet. Ital. 40 (2004) 601-610
26. Roy P., Urakawa T., Van Dijk A.A., and Erasmus B.J. Recombinant virus vaccine for bluetongue disease in sheep. J. Virol. 64 (1990) 1998-2003
27. Roy P., French T., and Erasmus B.J. Protective efficacy of virus-like particles for bluetongue disease. Vaccine 10 (1992) 28-32
28. Roy P., Bishop D.H., LeBlois H., and Erasmus B.J. Long-lasting protection of sheep against bluetongue challenge after vaccination with virus-like particles: evidence for homologous and partial heterologous protection. Vaccine 12 (1994) 805-811
29. Roy P. Genetically engineered structure-based vaccine for bluetongue disease. Vet. Ital. 40 (2004) 594-600
30. Saegerman, C., Berkvens, D., Mellor, P.S., 2008. Bluetongue epidemiology in the European Union. Emerg. Infect. Dis. [serial on the Internet]. 2008 Apr [date cited]. Available from http://www.cdc.gov/EID/content/14/4/539.htm.
31. Savini G., Monaco F., Facchinei A., Pinoni C., Salucci S., Cofini F., et al. Field vaccination of sheep with bivalent modified-live vaccine against bluetongue virus serotypes 2 and 9: effect on milk production. Vet. Ital. 40 (2003) 627-630
32. Savini, G., Monaco, F., Citarella, R., Calzetta, G., Panichi, G., Ruiu, A. and Caporale, V., 2004. Monovalent modified vaccine against bluetongue virus serotype 2: immunity studies in cows. In Bluetongue, Part II (N.J. MacLachlan and J.E. Pearson (Eds.). Proc. Third International Symposium, Taormina, 26-29 October. Vet. Ital. 40, 664-667.
33. Savini G., Nicolussi P., Pilo G., Colorito P., Fresi S., Teodori L., Leone A., Bonfini B., and Patta C. Study of the safety and efficacy of a recombinant vaccine for bluetongue virus serotype 2. Vet. Ital. 43 (2007) 815-820
34. Savini G., MacLachlan N.J., Calistri P., Sanchez-Vizcaino J.M., and Zientara S. Vaccines against bluetongue in Europe. Comparat. Immunol. Microbiol. Infect. Dis. (2007) 006 10.1016/j.cimid.2007.07
35. Siegel S., and Castellan Jr. N.J. Nonparametric Statistic for Behavioral Sciences. 2nd edition. (1988), McGraw-Hill International Editions (Statistic series), New York, NY, USA
36. Sivia D.S. Data Analysis-A Bayesian Tutorial (1996), Oxford University Press
37. Tabachnick W.J. Culicoides and the global epidemiology of bluetongue virus infection. Vet. Ital. 40 (2004) 145-150
38. Toussaint J.F., Vandenbussche F., Mast J., De Meester L., Goris N., Van Dessel W., Vanopdenbosche E., Kerkhofs P., De Clercq K., Zientara S., Sailleau C., Czaplicki G., Depoorter G., and Dochy J.M. Bluetongue in northern Europe. Vet. Record 159 (2006) 327
39. Venter G.J., Gerdes G.H., Mellor P.S., and Paweska J.T. Transmission potential of South African Culicoides species for live-attenuated bluetongue virus. Vet. Ital. 40 (2004) 198-202
40. Veronesi E., Hamblin C., and Mellor P.S. Live attenuated bluetongue virus vaccine viruses in Dorset poll sheep, before and after passage in vector midges (Diptera: Ceratopogonidae). Vaccine 23 (2005) 5509-5516
41. Verwoerd D., and Erasmus B.J. Bluetongue. In: Coetzer J.A., and Tustin R.C. (Eds). Infectious Diseases of Livestock. 2nd ed. (2004), Oxford University Press, Cape Town 1201-1220